These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine. Ducloux D; Fournier V; Rebibou JM; Bresson-Vautrin C; Gibey R; Chalopin JM Clin Nephrol; 1998 Apr; 49(4):232-5. PubMed ID: 9582553 [TBL] [Abstract][Full Text] [Related]
8. Effect of folic acid therapy on serum homocysteine level in renal transplant recipients. Savaj S; Rezakhani S; Porooshani F; Ghods AJ Transplant Proc; 2002 Sep; 34(6):2419. PubMed ID: 12270462 [No Abstract] [Full Text] [Related]
9. Hyperhomocysteinemia and assessment of its associated factors in renal transplant recipients: a single-center study in northern Iran. Monfared A; Azimi SZ; Kazemnezhad E; Khosravi M; Lebadi M; Mirzajani E; Ashtiani MN Transplantation; 2014 Jul; 98(1):66-71. PubMed ID: 24978036 [TBL] [Abstract][Full Text] [Related]
10. Plasma homocysteine levels in renal transplant patients on tacrolimus therapy. Akbas SH; Tuncer M; Gurkan A; Yucetin L; Yavuz A; Demirbas A; Ersoy F; Gultekin M; Yakupoglu G; Akaydin M Transplant Proc; 2004; 36(1):159-60. PubMed ID: 15013332 [TBL] [Abstract][Full Text] [Related]
11. Influence of anticalcineurinic therapy in plasma homocysteine levels of renal transplant recipients: a prospective study. Laurés AS; Gomez E; Alvarez V; Coto E; Baltar J; Alvarez-Grande J Transplant Proc; 2003 Aug; 35(5):1739-41. PubMed ID: 12962777 [TBL] [Abstract][Full Text] [Related]
12. A retrospective analysis of Neoral C2 monitoring in Chinese renal transplantation recipients. Tan J; Tang X Transplant Proc; 2003 Feb; 35(1):232-3. PubMed ID: 12591377 [No Abstract] [Full Text] [Related]
13. Protective effect of folic acid on cyclosporine-induced bone loss in rats. Mohammadi A; Omrani L; Omrani LR; Kiani F; Eshraghian A; Azizi Z; Omrani GR Transpl Int; 2012 Jan; 25(1):127-33. PubMed ID: 22039919 [TBL] [Abstract][Full Text] [Related]
14. Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a novel cyclosporine formulation, using a dose-normalized equivalence method. First MR; Weiskittel P; Burton M; Shah M; Dreyer D; Fleck P; Bey C; Peddi R; Canafax D; Schroeder TJ Transplant Proc; 1998 Aug; 30(5):1701-5. PubMed ID: 9723249 [No Abstract] [Full Text] [Related]
15. Homocysteine levels among transplant recipients: effect of immunosuppressive protocols. Mor E; Helfmann L; Lustig S; Bar-Nathan N; Yussim A; Sela BA Transplant Proc; 2001 Sep; 33(6):2945-6. PubMed ID: 11543802 [No Abstract] [Full Text] [Related]